Timothy C. Allen, MD, JD, FCAP, is professor and chair of the pathology department at the University of Mississippi Medical Center in Jackson, Mississippi. Dr. Allen is certified by the American Board of Pathology in anatomic and clinical pathology, with added qualification in cytopathology. He is an associate editor of the Archives of Pathology and Laboratory Medicine, and author and coauthor of numerous articles and book chapters on pulmonary pathology and medico-legal issues. He is also coeditor of the Advances in Surgical Pathology series.
Dr. Allen serves as a governor on the College of American Pathologists Board of Governors. He is the immediate past-president of the Pulmonary Pathology Society and a past-president of the Texas Society of Pathologists.
Sandra M. Brown, MS, LCGC, is manager of the cancer genetics program at St. Joseph Hospital in Orange, California. Prior to joining St. Joseph Hospital, Ms. Brown served as the cancer genetic counselor for MemorialCare Health System. She is an active member of several international, national, state, and regional patient advocate, policy, and research networks for inherited cancers including ACCC, California Department of Health Care Services - Every Woman Counts, Lynch Syndrome Screening Network, Facing Our Risk of Cancer Empowered, Ovarian Cancer Orange County Alliance, and the International Clinical Cancer Genetics Community Research Network.
She frequently addresses professional, national association, and lay audiences; collaborates on important research; and provides leadership to cancer risk awareness campaigns and support groups. Ms. Brown obtained her master’s in human/medical genetics from the University of California, Irvine.
Pablo D. Gutman, MD, MBA, is medical director and chair of the pathology department at Holy Cross Health Cancer Institute (a 500+ bed hospital system in the Washington, D.C., metropolitan area). He is board certified in anatomical pathology, clinical pathology, hematopathology, and cytopathology. He has a special interested in optimizing tissue acquisition and processing for diagnosis and molecular testing.
Jeremiah Martin, MBBCh, MSCRD, FRCSI, is a thoracic and cardiac surgeon at Southern Ohio Medical Center. He completed his minimally invasive thoracic surgery and lung transplantation fellowship at Duke University Hospital in 2012.
Dr. Martin practiced at the University of Kentucky for four years before moving to Southern Ohio where he has resided for over two years.
Mohamed K. Mohamed, MD, PhD, is a practicing hematologist and oncologist, and director of the Thoracic Oncology Program at Cone Health Cancer Center in Greensboro, North Carolina. Dr. Mohamed specializes in internal medicine and oncology. He completed his hematology/oncology fellowship at the University of Pittsburgh.
Jan Nowak, MD, PhD, is clinical chief of molecular pathology and professor of oncology at Roswell Park Comprehensive Cancer Center. Dr. Nowak is certified in molecular genetic pathology and anatomic and clinical pathology. His areas of expertise include anatomic, clinical, and molecular pathology; laboratory management; laboratory regulatory oversight; and laboratory and professional services coding and reimbursement.
Dr. Nowak obtained his medical degree from the University of Rochester School of Medicine and doctorate in biophysics from the University of Rochester in Rochester, New York.
Michelle Shiller, DO, AP/CP, MGP, became board certified in Anatomic, Clinical, and Molecular Genetic Pathology following the completion of her residency at Baylor University Medical Center in Dallas, Texas, and her fellowship at The Mayo Clinic in Rochester, Minnesota. Upon completion of her training, Dr. Shiller established a practice with Pathologists Biomedical Laboratories in Dallas, Texas, which services the majority of the Dallas/Ft. Worth Metroplex Baylor Scott and White Hospitals. Dr. Shiller sits on the Quality Committee for the Baylor Sammons Cancer Center; serves as the Assistant Medical Director for Cancer Genetics, primarily focusing on germline cancer predisposition; and is the Co-Assistant Medical Director for the Division of Molecular Medicine and Pathology. Dr. Shiller has also served on the Baylor Medical Board. Dr. Shiller has served on steering committees and advisory boards for multiple entities. She is an active member of the Association for Molecular Pathology, where she has developed a consistent dialogue between molecular pathology and oncology, and she assists with developing the ASCO-sponsored Molecular Tumor Board..